+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proteomics Market By Component, By Application: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 280 Pages
  • April 2024
  • Region: Global
  • Allied Market Research
  • ID: 5306452
The global proteomics market was valued at $32.8 billion in 2023 and is projected to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035. Proteomics is a branch of molecular biology that focuses on the study of proteins, their structures, functions, and interactions within a biological system. Unlike genomics, which deals with the study of an organism's entire genome, proteomics specifically targets the proteome, which refers to the complete set of proteins expressed by a cell, tissue, or organism. The field of proteomics encompasses various techniques and methodologies aimed at understanding the roles and behaviors of proteins in biological processes, including protein expression profiling, protein-protein interactions, post-translational modifications, and protein localization.

The proteomics market growth is attributed to high adoption of proteomics in disease diagnosis, technological advancements, and increase in research in life sciences. Proteomics, the large-scale study of proteins, offers a comprehensive understanding of the dynamic interplay between proteins within biological systems, shedding light on disease pathogenesis and progression. According to a 2021 article by National Library of Medicine, it was reported that cancer proteomics unraveled key information in mechanistic studies on tumor growth and metastasis, which has contributed to the identification of clinically applicable biomarkers as well as therapeutic targets. With advancements in technology, such as mass spectrometry and protein microarray techniques, proteomics enables researchers and clinicians to identify biomarkers indicative of specific diseases with unprecedented accuracy and sensitivity. Thus, the increasing adoption of proteomics in disease diagnosis is expected to drive growth of proteomics industry.The proteomics market is experiencing a significant surge, largely driven by the increasing emphasis on research in the life sciences sector. As scientific understanding deepens and technological advancements accelerate, the demand for proteomics solutions has grown exponentially. Proteomics, the study of proteins and their functions within biological systems, plays a pivotal role in elucidating complex cellular mechanisms, disease pathways, and drug interactions. With life sciences research expanding across various disciplines such as genomics, transcriptomics, and metabolomics, proteomics has emerged as a complementary tool offering crucial insights into the intricate workings of biological systems. For instance, according to 2021 report by National Library of Medicine, it was reported that proteomics has become an important field in molecular sciences, as it provides valuable information on the identity, expression levels, and modification of proteins. Moreover, the rise of personalized medicine and the quest for targeted therapies have fueled the need for precise protein analysis techniques. This has propelled investments in proteomics technologies, including mass spectrometry, protein microarrays, and bioinformatics solutions, to develop more accurate diagnostic tools and therapeutic interventions. Thus, the rise in research in the life sciences sector is expected to drive the growth of the market.The proteomics market is segmented on the basis of component, application, and region. By component, the market is divided into reagents, instruments and services. By application, the market is divided into drug discovery, diseases diagnosis, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).Major key players that operate in the proteomics market are Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, Waters Corporation, Perkin Elmer Inc, Horiba Ltd., Merck KGaA, Agilent Technologies Inc., Li-Cor Inc. Key players have adopted collaboration, and product launch as a key developmental strategy to improve the product portfolio of the proteomics market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2023 to 2035 to identify the prevailing proteomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Component

  • Reagents
  • Reagents Type
  • Microarray
  • X Ray Crystallography
  • Spectrometry
  • Chromatography
  • Electrophoresis
  • Immunoassay
  • Protein Fractionation Reagents
  • Instruments
  • Instruments Type
  • Microarray
  • Spectrometry
  • Chromatography
  • Electrophoresis
  • Surface Plasmon Resonace
  • X Ray Crystallography
  • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Waters Corporation
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc.
  • Li-Cor Inc
  • Bruker Corporation- Perkin Elmer Inc
  • Danaher Corporation- Horiba Ltd.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: PROTEOMICS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Reagents Proteomics Market by Reagents Type
4.3. Instruments
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Instruments Proteomics Market by Instruments Type
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PROTEOMICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug Discovery
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Disease Diagnosis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: PROTEOMICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Component
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Component
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Component
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Component
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Component
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Component
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Component
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Component
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Component
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Component
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Component
6.3.4.6.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Component
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Component
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Component
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Component
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Component
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Component
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Component
6.4.4.6.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Component
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Component
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Component
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Component
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Component
6.5.4.4.2. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Thermo Fisher Scientific Inc.
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Merck KGaA
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Waters Corporation
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Bio-Rad Laboratories Inc
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Agilent Technologies Inc.
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Li-Cor Inc
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Bruker Corporation
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Perkin Elmer Inc
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Danaher Corporation
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Horiba Ltd.
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Proteomics Market, by Component, 2023-2035 ($Million)
Table 02. Proteomics Market for Reagents, by Region, 2023-2035 ($Million)
Table 03. Global Reagents Proteomics Market, by Reagents Type, 2023-2035 ($Million)
Table 04. Proteomics Market for Instruments, by Region, 2023-2035 ($Million)
Table 05. Global Instruments Proteomics Market, by Instruments Type, 2023-2035 ($Million)
Table 06. Proteomics Market for Services, by Region, 2023-2035 ($Million)
Table 07. Global Proteomics Market, by Application, 2023-2035 ($Million)
Table 08. Proteomics Market for Drug Discovery, by Region, 2023-2035 ($Million)
Table 09. Proteomics Market for Disease Diagnosis, by Region, 2023-2035 ($Million)
Table 10. Proteomics Market for Others, by Region, 2023-2035 ($Million)
Table 11. Proteomics Market, by Region, 2023-2035 ($Million)
Table 12. North America Proteomics Market, by Component, 2023-2035 ($Million)
Table 13. North America Proteomics Market, by Application, 2023-2035 ($Million)
Table 14. North America Proteomics Market, by Country, 2023-2035 ($Million)
Table 15. U.S. Proteomics Market, by Component, 2023-2035 ($Million)
Table 16. U.S. Proteomics Market, by Application, 2023-2035 ($Million)
Table 17. Canada Proteomics Market, by Component, 2023-2035 ($Million)
Table 18. Canada Proteomics Market, by Application, 2023-2035 ($Million)
Table 19. Mexico Proteomics Market, by Component, 2023-2035 ($Million)
Table 20. Mexico Proteomics Market, by Application, 2023-2035 ($Million)
Table 21. Europe Proteomics Market, by Component, 2023-2035 ($Million)
Table 22. Europe Proteomics Market, by Application, 2023-2035 ($Million)
Table 23. Europe Proteomics Market, by Country, 2023-2035 ($Million)
Table 24. Germany Proteomics Market, by Component, 2023-2035 ($Million)
Table 25. Germany Proteomics Market, by Application, 2023-2035 ($Million)
Table 26. France Proteomics Market, by Component, 2023-2035 ($Million)
Table 27. France Proteomics Market, by Application, 2023-2035 ($Million)
Table 28. UK Proteomics Market, by Component, 2023-2035 ($Million)
Table 29. UK Proteomics Market, by Application, 2023-2035 ($Million)
Table 30. Italy Proteomics Market, by Component, 2023-2035 ($Million)
Table 31. Italy Proteomics Market, by Application, 2023-2035 ($Million)
Table 32. Spain Proteomics Market, by Component, 2023-2035 ($Million)
Table 33. Spain Proteomics Market, by Application, 2023-2035 ($Million)
Table 34. Rest of Europe Proteomics Market, by Component, 2023-2035 ($Million)
Table 35. Rest of Europe Proteomics Market, by Application, 2023-2035 ($Million)
Table 36. Asia-Pacific Proteomics Market, by Component, 2023-2035 ($Million)
Table 37. Asia-Pacific Proteomics Market, by Application, 2023-2035 ($Million)
Table 38. Asia-Pacific Proteomics Market, by Country, 2023-2035 ($Million)
Table 39. Japan Proteomics Market, by Component, 2023-2035 ($Million)
Table 40. Japan Proteomics Market, by Application, 2023-2035 ($Million)
Table 41. China Proteomics Market, by Component, 2023-2035 ($Million)
Table 42. China Proteomics Market, by Application, 2023-2035 ($Million)
Table 43. India Proteomics Market, by Component, 2023-2035 ($Million)
Table 44. India Proteomics Market, by Application, 2023-2035 ($Million)
Table 45. Australia Proteomics Market, by Component, 2023-2035 ($Million)
Table 46. Australia Proteomics Market, by Application, 2023-2035 ($Million)
Table 47. South Korea Proteomics Market, by Component, 2023-2035 ($Million)
Table 48. South Korea Proteomics Market, by Application, 2023-2035 ($Million)
Table 49. Rest of Asia-Pacific Proteomics Market, by Component, 2023-2035 ($Million)
Table 50. Rest of Asia-Pacific Proteomics Market, by Application, 2023-2035 ($Million)
Table 51. LAMEA Proteomics Market, by Component, 2023-2035 ($Million)
Table 52. LAMEA Proteomics Market, by Application, 2023-2035 ($Million)
Table 53. LAMEA Proteomics Market, by Country, 2023-2035 ($Million)
Table 54. Brazil Proteomics Market, by Component, 2023-2035 ($Million)
Table 55. Brazil Proteomics Market, by Application, 2023-2035 ($Million)
Table 56. Saudi Arabia Proteomics Market, by Component, 2023-2035 ($Million)
Table 57. Saudi Arabia Proteomics Market, by Application, 2023-2035 ($Million)
Table 58. South Africa Proteomics Market, by Component, 2023-2035 ($Million)
Table 59. South Africa Proteomics Market, by Application, 2023-2035 ($Million)
Table 60. Rest of LAMEA Proteomics Market, by Component, 2023-2035 ($Million)
Table 61. Rest of LAMEA Proteomics Market, by Application, 2023-2035 ($Million)
Table 62. Thermo Fisher Scientific Inc.: Key Executives
Table 63. Thermo Fisher Scientific Inc.: Company Snapshot
Table 64. Thermo Fisher Scientific Inc.: Product Segments
Table 65. Thermo Fisher Scientific Inc.: Service Segments
Table 66. Thermo Fisher Scientific Inc.: Product Portfolio
Table 67. Thermo Fisher Scientific Inc.: Key Strategies
Table 68. Merck KGaA: Key Executives
Table 69. Merck KGaA: Company Snapshot
Table 70. Merck KGaA: Product Segments
Table 71. Merck KGaA: Service Segments
Table 72. Merck KGaA: Product Portfolio
Table 73. Merck KGaA: Key Strategies
Table 74. Waters Corporation: Key Executives
Table 75. Waters Corporation: Company Snapshot
Table 76. Waters Corporation: Product Segments
Table 77. Waters Corporation: Service Segments
Table 78. Waters Corporation: Product Portfolio
Table 79. Waters Corporation: Key Strategies
Table 80. Bio-Rad Laboratories Inc.: Key Executives
Table 81. Bio-Rad Laboratories Inc.: Company Snapshot
Table 82. Bio-Rad Laboratories Inc.: Product Segments
Table 83. Bio-Rad Laboratories Inc.: Service Segments
Table 84. Bio-Rad Laboratories Inc.: Product Portfolio
Table 85. Bio-Rad Laboratories Inc.: Key Strategies
Table 86. Agilent Technologies Inc.: Key Executives
Table 87. Agilent Technologies Inc.: Company Snapshot
Table 88. Agilent Technologies Inc.: Product Segments
Table 89. Agilent Technologies Inc.: Service Segments
Table 90. Agilent Technologies Inc.: Product Portfolio
Table 91. Agilent Technologies Inc.: Key Strategies
Table 92. Li-Cor Inc.: Key Executives
Table 93. Li-Cor Inc.: Company Snapshot
Table 94. Li-Cor Inc.: Product Segments
Table 95. Li-Cor Inc.: Service Segments
Table 96. Li-Cor Inc.: Product Portfolio
Table 97. Li-Cor Inc.: Key Strategies
Table 98. Bruker Corporation: Key Executives
Table 99. Bruker Corporation: Company Snapshot
Table 100. Bruker Corporation: Product Segments
Table 101. Bruker Corporation: Service Segments
Table 102. Bruker Corporation: Product Portfolio
Table 103. Bruker Corporation: Key Strategies
Table 104. Perkin Elmer Inc.: Key Executives
Table 105. Perkin Elmer Inc.: Company Snapshot
Table 106. Perkin Elmer Inc.: Product Segments
Table 107. Perkin Elmer Inc.: Service Segments
Table 108. Perkin Elmer Inc.: Product Portfolio
Table 109. Perkin Elmer Inc.: Key Strategies
Table 110. Danaher Corporation: Key Executives
Table 111. Danaher Corporation: Company Snapshot
Table 112. Danaher Corporation: Product Segments
Table 113. Danaher Corporation: Service Segments
Table 114. Danaher Corporation: Product Portfolio
Table 115. Danaher Corporation: Key Strategies
Table 116. Horiba Ltd.: Key Executives
Table 117. Horiba Ltd.: Company Snapshot
Table 118. Horiba Ltd.: Product Segments
Table 119. Horiba Ltd.: Service Segments
Table 120. Horiba Ltd.: Product Portfolio
Table 121. Horiba Ltd.: Key Strategies
List of Figures
Figure 01. Proteomics Market, 2023-2035
Figure 02. Segmentation of Proteomics Market,2023-2035
Figure 03. Top Impacting Factors in Proteomics Market
Figure 04. Top Investment Pockets in Proteomics Market (2024-2035)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Proteomics Market:Drivers, Restraints and Opportunities
Figure 11. Proteomics Market, by Component, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Proteomics Market for Reagents, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Proteomics Market for Instruments, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Proteomics Market for Services, by Country 2023 and 2035(%)
Figure 15. Proteomics Market, by Application, 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Proteomics Market for Drug Discovery, by Country 2023 and 2035(%)
Figure 17. Comparative Share Analysis of Proteomics Market for Disease Diagnosis, by Country 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Proteomics Market for Others, by Country 2023 and 2035(%)
Figure 19. Proteomics Market by Region, 2023 and 2035(%)
Figure 20. U.S. Proteomics Market, 2023-2035 ($Million)
Figure 21. Canada Proteomics Market, 2023-2035 ($Million)
Figure 22. Mexico Proteomics Market, 2023-2035 ($Million)
Figure 23. Germany Proteomics Market, 2023-2035 ($Million)
Figure 24. France Proteomics Market, 2023-2035 ($Million)
Figure 25. UK Proteomics Market, 2023-2035 ($Million)
Figure 26. Italy Proteomics Market, 2023-2035 ($Million)
Figure 27. Spain Proteomics Market, 2023-2035 ($Million)
Figure 28. Rest of Europe Proteomics Market, 2023-2035 ($Million)
Figure 29. Japan Proteomics Market, 2023-2035 ($Million)
Figure 30. China Proteomics Market, 2023-2035 ($Million)
Figure 31. India Proteomics Market, 2023-2035 ($Million)
Figure 32. Australia Proteomics Market, 2023-2035 ($Million)
Figure 33. South Korea Proteomics Market, 2023-2035 ($Million)
Figure 34. Rest of Asia-Pacific Proteomics Market, 2023-2035 ($Million)
Figure 35. Brazil Proteomics Market, 2023-2035 ($Million)
Figure 36. Saudi Arabia Proteomics Market, 2023-2035 ($Million)
Figure 37. South Africa Proteomics Market, 2023-2035 ($Million)
Figure 38. Rest of LAMEA Proteomics Market, 2023-2035 ($Million)
Figure 39. Top Winning Strategies, by Year
Figure 40. Top Winning Strategies, by Development
Figure 41. Top Winning Strategies, by Company
Figure 42. Product Mapping of Top 10 Players
Figure 43. Competitive Dashboard
Figure 44. Competitive Heatmap: Proteomics Market
Figure 45. Top Player Positioning, 2023

Companies Mentioned

Key Market Players in the Proteomics Market include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Waters Corporation
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc.
  • Li-Cor Inc
  • Bruker Corporation
  • Perkin Elmer Inc
  • Danaher Corporation
  • Horiba Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information